Diagnostik und Therapie des hepatozellulären Karzinoms

Standard

Diagnostik und Therapie des hepatozellulären Karzinoms. / Greten, T F; Malek, N P; Schmidt, S; Arends, J; Bartenstein, P; Bechstein, W; Bernatik, T; Bitzer, M; Chavan, A; Dollinger, M; Domagk, D; Drognitz, O; Düx, M; Farkas, S; Folprecht, G; Galle, P; Geißler, M; Gerken, G; Habermehl, D; Helmberger, T; Herfarth, K; Hoffmann, R T; Holtmann, M; Huppert, P; Jakobs, T; Keller, M; Klempnauer, J; Kolligs, F; Körber, J; Lang, H; Lehner, F; Lordick, F; Lubienski, A; Manns, M P; Mahnken, A; Möhler, M; Mönch, C; Neuhaus, P; Niederau, C; Ocker, M; Otto, G; Pereira, P; Pott, G; Riemer, J; Ringe, K; Ritterbusch, U; Rummeny, E; Schirmacher, P; Schlitt, H J; Schlottmann, K; Schmitz, V; Schuler, A; Schulze-Bergkamen, H; von Schweinitz, D; Seehofer, D; Sitter, H; Straßburg, C P; Stroszczynski, C; Strobel, D; Tannapfel, A; Trojan, J; van Thiel, I; Vogel, A; Wacker, F; Wedemeyer, H; Wege, H; Weinmann, A; Wittekind, C; Wörmann, B; Zech, C J.

in: Z GASTROENTEROL, Jahrgang 51, Nr. 11, 01.11.2013, S. 1269-326.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Greten, TF, Malek, NP, Schmidt, S, Arends, J, Bartenstein, P, Bechstein, W, Bernatik, T, Bitzer, M, Chavan, A, Dollinger, M, Domagk, D, Drognitz, O, Düx, M, Farkas, S, Folprecht, G, Galle, P, Geißler, M, Gerken, G, Habermehl, D, Helmberger, T, Herfarth, K, Hoffmann, RT, Holtmann, M, Huppert, P, Jakobs, T, Keller, M, Klempnauer, J, Kolligs, F, Körber, J, Lang, H, Lehner, F, Lordick, F, Lubienski, A, Manns, MP, Mahnken, A, Möhler, M, Mönch, C, Neuhaus, P, Niederau, C, Ocker, M, Otto, G, Pereira, P, Pott, G, Riemer, J, Ringe, K, Ritterbusch, U, Rummeny, E, Schirmacher, P, Schlitt, HJ, Schlottmann, K, Schmitz, V, Schuler, A, Schulze-Bergkamen, H, von Schweinitz, D, Seehofer, D, Sitter, H, Straßburg, CP, Stroszczynski, C, Strobel, D, Tannapfel, A, Trojan, J, van Thiel, I, Vogel, A, Wacker, F, Wedemeyer, H, Wege, H, Weinmann, A, Wittekind, C, Wörmann, B & Zech, CJ 2013, 'Diagnostik und Therapie des hepatozellulären Karzinoms', Z GASTROENTEROL, Jg. 51, Nr. 11, S. 1269-326. https://doi.org/10.1055/s-0033-1355841

APA

Greten, T. F., Malek, N. P., Schmidt, S., Arends, J., Bartenstein, P., Bechstein, W., Bernatik, T., Bitzer, M., Chavan, A., Dollinger, M., Domagk, D., Drognitz, O., Düx, M., Farkas, S., Folprecht, G., Galle, P., Geißler, M., Gerken, G., Habermehl, D., ... Zech, C. J. (2013). Diagnostik und Therapie des hepatozellulären Karzinoms. Z GASTROENTEROL, 51(11), 1269-326. https://doi.org/10.1055/s-0033-1355841

Vancouver

Greten TF, Malek NP, Schmidt S, Arends J, Bartenstein P, Bechstein W et al. Diagnostik und Therapie des hepatozellulären Karzinoms. Z GASTROENTEROL. 2013 Nov 1;51(11):1269-326. https://doi.org/10.1055/s-0033-1355841

Bibtex

@article{f9664dc835414201aed281ede265675b,
title = "Diagnostik und Therapie des hepatozellul{\"a}ren Karzinoms",
abstract = "The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence- and consensus-based instrument that is aimed at improving the diagnosis of and therapy for HCC since these are very challenging tasks. The purpose of the guidelines is to offer the patient (with suspected or confirmed HCC) adequate, scientifically based and up-to-date procedures in diagnosis, therapy and rehabilitation. This holds not only for locally limited or focally advanced disease but also for the existence of recurrences or distant metastases. Besides making a contribution to an appropriate health-care service, the guidelines should also provide the foundation for an individually adapted, high-quality therapy. The explanatory background texts should also enable non-specialist but responsible colleagues to give sound advice to their patients concerning specialist procedures, side effects and results. In the medium and long-term this should reduce the morbidity and mortality of patients with HCC and improve their quality of life.",
author = "Greten, {T F} and Malek, {N P} and S Schmidt and J Arends and P Bartenstein and W Bechstein and T Bernatik and M Bitzer and A Chavan and M Dollinger and D Domagk and O Drognitz and M D{\"u}x and S Farkas and G Folprecht and P Galle and M Gei{\ss}ler and G Gerken and D Habermehl and T Helmberger and K Herfarth and Hoffmann, {R T} and M Holtmann and P Huppert and T Jakobs and M Keller and J Klempnauer and F Kolligs and J K{\"o}rber and H Lang and F Lehner and F Lordick and A Lubienski and Manns, {M P} and A Mahnken and M M{\"o}hler and C M{\"o}nch and P Neuhaus and C Niederau and M Ocker and G Otto and P Pereira and G Pott and J Riemer and K Ringe and U Ritterbusch and E Rummeny and P Schirmacher and Schlitt, {H J} and K Schlottmann and V Schmitz and A Schuler and H Schulze-Bergkamen and {von Schweinitz}, D and D Seehofer and H Sitter and Stra{\ss}burg, {C P} and C Stroszczynski and D Strobel and A Tannapfel and J Trojan and {van Thiel}, I and A Vogel and F Wacker and H Wedemeyer and H Wege and A Weinmann and C Wittekind and B W{\"o}rmann and Zech, {C J}",
note = "Leitlinie",
year = "2013",
month = nov,
day = "1",
doi = "10.1055/s-0033-1355841",
language = "Deutsch",
volume = "51",
pages = "1269--326",
journal = "Z GASTROENTEROL",
issn = "0044-2771",
publisher = "Karl Demeter Verlag GmbH",
number = "11",

}

RIS

TY - JOUR

T1 - Diagnostik und Therapie des hepatozellulären Karzinoms

AU - Greten, T F

AU - Malek, N P

AU - Schmidt, S

AU - Arends, J

AU - Bartenstein, P

AU - Bechstein, W

AU - Bernatik, T

AU - Bitzer, M

AU - Chavan, A

AU - Dollinger, M

AU - Domagk, D

AU - Drognitz, O

AU - Düx, M

AU - Farkas, S

AU - Folprecht, G

AU - Galle, P

AU - Geißler, M

AU - Gerken, G

AU - Habermehl, D

AU - Helmberger, T

AU - Herfarth, K

AU - Hoffmann, R T

AU - Holtmann, M

AU - Huppert, P

AU - Jakobs, T

AU - Keller, M

AU - Klempnauer, J

AU - Kolligs, F

AU - Körber, J

AU - Lang, H

AU - Lehner, F

AU - Lordick, F

AU - Lubienski, A

AU - Manns, M P

AU - Mahnken, A

AU - Möhler, M

AU - Mönch, C

AU - Neuhaus, P

AU - Niederau, C

AU - Ocker, M

AU - Otto, G

AU - Pereira, P

AU - Pott, G

AU - Riemer, J

AU - Ringe, K

AU - Ritterbusch, U

AU - Rummeny, E

AU - Schirmacher, P

AU - Schlitt, H J

AU - Schlottmann, K

AU - Schmitz, V

AU - Schuler, A

AU - Schulze-Bergkamen, H

AU - von Schweinitz, D

AU - Seehofer, D

AU - Sitter, H

AU - Straßburg, C P

AU - Stroszczynski, C

AU - Strobel, D

AU - Tannapfel, A

AU - Trojan, J

AU - van Thiel, I

AU - Vogel, A

AU - Wacker, F

AU - Wedemeyer, H

AU - Wege, H

AU - Weinmann, A

AU - Wittekind, C

AU - Wörmann, B

AU - Zech, C J

N1 - Leitlinie

PY - 2013/11/1

Y1 - 2013/11/1

N2 - The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence- and consensus-based instrument that is aimed at improving the diagnosis of and therapy for HCC since these are very challenging tasks. The purpose of the guidelines is to offer the patient (with suspected or confirmed HCC) adequate, scientifically based and up-to-date procedures in diagnosis, therapy and rehabilitation. This holds not only for locally limited or focally advanced disease but also for the existence of recurrences or distant metastases. Besides making a contribution to an appropriate health-care service, the guidelines should also provide the foundation for an individually adapted, high-quality therapy. The explanatory background texts should also enable non-specialist but responsible colleagues to give sound advice to their patients concerning specialist procedures, side effects and results. In the medium and long-term this should reduce the morbidity and mortality of patients with HCC and improve their quality of life.

AB - The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence- and consensus-based instrument that is aimed at improving the diagnosis of and therapy for HCC since these are very challenging tasks. The purpose of the guidelines is to offer the patient (with suspected or confirmed HCC) adequate, scientifically based and up-to-date procedures in diagnosis, therapy and rehabilitation. This holds not only for locally limited or focally advanced disease but also for the existence of recurrences or distant metastases. Besides making a contribution to an appropriate health-care service, the guidelines should also provide the foundation for an individually adapted, high-quality therapy. The explanatory background texts should also enable non-specialist but responsible colleagues to give sound advice to their patients concerning specialist procedures, side effects and results. In the medium and long-term this should reduce the morbidity and mortality of patients with HCC and improve their quality of life.

U2 - 10.1055/s-0033-1355841

DO - 10.1055/s-0033-1355841

M3 - SCORING: Zeitschriftenaufsatz

C2 - 24243572

VL - 51

SP - 1269

EP - 1326

JO - Z GASTROENTEROL

JF - Z GASTROENTEROL

SN - 0044-2771

IS - 11

ER -